David R Epstein, Director at AgomAb Therapeutics, bought AGMB on Oct 8, 2026

Data as of Oct 16

▲ BUY$44.5K5,000 shares at $8.90David R Epstein DirectorAGMB AgomAb Therapeutics NV

Watch AGMB

Traded: Oct 8, 2026
Disclosed: Oct 9, 2026
Filed: 1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

AGMBSimilar stocks (XLV — its sector index fund), rebased to AGMB's price on the disclosure day

AGMB since disclosure

−8.8%

Similar stocks (XLV) since disclosure

+3.5%

XLV — its sector index fund

Change in closing price from Oct 9, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

⚪ 3+ insiders buy after a 30% drop — fired on this trade
Not enough evidence · In past tests: 8.0 percentage points better than similar stocks over 3 months · 2,952 tries
⚪ CFO buys $25K+ of own stock — fired on this disclosure day
Not enough evidence · In past tests: 3.6 percentage points better than similar stocks over 3 months · 2,178 tries

What this rule is doing with AGMB right now

See pricing →

Already a member? Sign in

See every trade on AGMB →